PRGO Q4 2025 Earnings — Perrigo Company plc Revenue & Financial Results | Market Cap Arena

PRGOPerrigo Company plc

$1B

Q4 2025 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$1.1B-2.5% YoY

Gross Profit

$362M32.6% margin

Operating Income

$85M7.6% margin

Net Income

-$1.4B-127.8% margin

EPS (Diluted)

$-10.23

QoQ Revenue Growth

+6.4%

Cash Flow

Operating Cash Flow

$175M

Free Cash Flow

$149M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$8.5B

Total Liabilities

$5.6B

Stockholders' Equity

$2.9B

Cash & Equivalents

$532M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$1.1B	$1.1B	-2.5%
Gross Profit	$362M	$386M	-6.1%
Operating Income	$85M	$114M	-25.8%
Net Income	-$1.4B	-$45M	-3086.7%

Revenue Segments

Consumer Self-Care Americas

$697M63%

Consumer Self-Care International

$413M37%

Geographic Segments

UNITED STATES

$685M61%

Europe

$398M35%

Other Geographical Areas

$27M2%

IRELAND

$13M1%